cyproterone acetate, ethinyl estradiol drug combination and Overweight

cyproterone acetate, ethinyl estradiol drug combination has been researched along with Overweight in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Abdel-Maboud, M; Abdelraoof, MI; Alshandidy, M; Eid, M; Hasabo, EA; Menshawy, A; Menshawy, E; Outani, O	1
Gu, M; Mueck, AO; Ruan, X; Song, J; Wang, H; Wang, L	2
de Zegher, F; Díaz, M; Ibáñez, L; López-Bermejo, A; Marcos, MV; Sebastiani, G	1

Reviews

1 review(s) available for cyproterone acetate, ethinyl estradiol drug combination and Overweight

Article	Year
The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials. PloS one, 2021, Volume: 16, Issue:7 Topics: Adult; Body Mass Index; Cholesterol, LDL; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Network Meta-Analysis; Obesity; Overweight; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Testosterone; Treatment Outcome; Triglycerides; Waist-Hip Ratio	2021

Article

Year

The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials.

PloS one, 2021, Volume: 16, Issue:7

Topics: Adult; Body Mass Index; Cholesterol, LDL; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Network Meta-Analysis; Obesity; Overweight; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Testosterone; Treatment Outcome; Triglycerides; Waist-Hip Ratio

2021

Trials

2 trial(s) available for cyproterone acetate, ethinyl estradiol drug combination and Overweight

Article	Year
Effect of Diane-35, alone or in combination with orlistat or metformin in Chinese polycystic ovary syndrome patients. Archives of gynecology and obstetrics, 2018, Volume: 297, Issue:6 Topics: Adipose Tissue; Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Treatment Outcome	2018
Oral contraception vs insulin sensitization for 18 months in nonobese adolescents with androgen excess: posttreatment differences in C-reactive protein, intima-media thickness, visceral adiposity, insulin sensitivity, and menstrual regularity. The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:5 Topics: Adiposity; Adolescent; Adolescent Development; Androgen Antagonists; Body Mass Index; C-Reactive Protein; Carotid Intima-Media Thickness; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hyperinsulinism; Insulin Resistance; Intra-Abdominal Fat; Menstruation Disturbances; Overweight; Tunica Intima; Vascular Diseases	2013

Article

Year

Effect of Diane-35, alone or in combination with orlistat or metformin in Chinese polycystic ovary syndrome patients.

Archives of gynecology and obstetrics, 2018, Volume: 297, Issue:6

Topics: Adipose Tissue; Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Treatment Outcome

2018

Oral contraception vs insulin sensitization for 18 months in nonobese adolescents with androgen excess: posttreatment differences in C-reactive protein, intima-media thickness, visceral adiposity, insulin sensitivity, and menstrual regularity.

The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:5

Topics: Adiposity; Adolescent; Adolescent Development; Androgen Antagonists; Body Mass Index; C-Reactive Protein; Carotid Intima-Media Thickness; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hyperinsulinism; Insulin Resistance; Intra-Abdominal Fat; Menstruation Disturbances; Overweight; Tunica Intima; Vascular Diseases

2013

Other Studies

1 other study(ies) available for cyproterone acetate, ethinyl estradiol drug combination and Overweight

Article	Year
Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2018, Volume: 34, Issue:5 Topics: Adult; Anti-Obesity Agents; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Lactones; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Young Adult	2018

Article

Year

Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2018, Volume: 34, Issue:5

Topics: Adult; Anti-Obesity Agents; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Lactones; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Young Adult

2018